Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia

NCT: NCT06686485 · ACTIVE_NOT_RECRUITING

NCT IDNCT06686485
StatusACTIVE_NOT_RECRUITING
Start Date2025-03-18
Completion2029-10-31
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

Subjects enrolled in the OPTION-A study will be clinically indicated for atrial fibrillation (AF) ablation procedure with the FARAPULSE™ PFA system and treatment with WATCHMAN LAAC Device, per physician's medical judgement and according to hospitals' standard of care during the same procedure.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑